European Commission issue statement on updates to Annexes VI, II, III, and V of new EU Cosmetics Regulation 1223/2009 and the substances banned by it.

European Commission issue statement on updates to Annexes VI, II, III, and V of new EU Cosmetics Regulation 1223/2009 and the substances banned by it.
CAMD aim to provide guidance on transitional provisions for manufacturers of medical devices and in-vitro devices under the new EU regulations.
There are no predefined rules in determining to what extent a manufacturer should investigate a medical device complaint, but there are several key facts and questions that may be used as a guidance. Read on this topic here.
Useful information on the scope and main changes introduced under the new European General Data Protection Regulation, entering into force in May 2018.
Switzerland aligns with EU medical device legislation to make crucial improvements to patient and consumer safety. The country expects to be aligned by 2020.
The Belgian Ministry of Foreign Affairs' new electronic apostille system for Free Sales Certificates will have a positive impact on legalization timeframes.
Find out more information on the European Directive increasing the safety requirements for cosmetic products.
The EU Competent Authorities for Medical Devices (CAMD) have recently released their FAQs to provide guidance on certain specific aspects concerning MDR/IVDR transition-related provisions.
Read more about it here.
As application designers have begun taking advantage of the advancements of technology and the growing patient trend for self-diagnosis and treatment, regulators have begun scrutinizing mobile medical apps.
How to plan for Brexit in light of the new General Data Protection Regulation (GDPR) in Europe. Follow some simple steps to compliance.